Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 1/20 | 0.62 |
| ▸ | GRM6 | O15303 | 1/20 | 0.62 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.62 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.62 |
| ▸ | GSR | P00390 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.62 |
| ▸ | GRM5 | P41594 | 1/20 | 0.62 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.62 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.62 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.62 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.62 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.62 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.62 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.62 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496858 | 1.00 | GRM8 (0.62) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Hydrochloric Acid SCHEMBL10636419 | 0.98 | GRM8 (0.60) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL3865479 | 0.92 | GRM8 (0.54) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL29286626 | 0.92 | GRM8 (0.54) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL3411544 | 0.92 | BLM (0.57) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL29240009 | 0.92 | BLM (0.57) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL1674762 | 0.92 | SLC1A1 (0.54) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL2917215 | 0.91 | GRM8 (0.58) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL435290 | 0.91 | GRM8 (0.58) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL2801193 | 0.90 | CYP1A2 (0.52) | GRM8GRM6GRIN2DGRIN3BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109467550-B | Synthesis method of phthalic diamide-L-glutamic anhydride | 苏州亚科科技股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20080026017-A1 | Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof | SAMI LABS LIMITED (IN) | 2008-01-31 | — | — | US | claimed |
| CN-101044188-A | Process for preparing glatiramer | SANDOZ AG (CH) | 2007-09-26 | — | — | CN | claimed |
| US-4600532-A | Process and composition for amino-terminal, α-aspartyl and α-glutamyl dipeptides and dipeptide esters | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1986-07-15 | — | — | US | claimed |
| JP-56169597-A | — | — | None | — | — | JP | disclosed |
| CN-113278548-B | Lactobacillus crispatus and application thereof in producing products for improving human vaginal environment | 南方医科大学珠江医院 | 2022-02-22 | — | — | CN | disclosed |
| CN-109467550-B | Synthesis method of phthalic diamide-L-glutamic anhydride | 苏州亚科科技股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-109467550-B | Synthesis method of phthalic diamide-L-glutamic anhydride | 苏州亚科科技股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-109467550-B | Synthesis method of phthalic diamide-L-glutamic anhydride | 苏州亚科科技股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-108349877-B | Novel citric acid derivatives | 爱迪生物股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-1986602-B | Synthesis process of polyacrylamide-poly (L-glutamic acid)-benzyl ester graft copolymer | UNIV LIAONING | 2010-05-12 | — | — | CN | disclosed |
| CN-100509862-C | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer | UNIV LIAONING (CN) | 2009-07-08 | — | — | CN | disclosed |
| CN-1986602-A | Synthesis process of polyacrylamide-poly (L-glutamic acid)-benzyl ester graft copolymer | UNIV LIAONING (CN) | 2007-06-27 | — | — | CN | disclosed |
| CN-1974605-A | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer | UNIV LIAONING (CN) | 2007-06-06 | — | — | CN | disclosed |
| JP-S56169597-A | MEASUREMENT OF GAMMA-GLUTAMYL TRANS PEPTIDASE ACTIVITY | EIKEN KAGAKU KK | 1981-12-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080026017-A1 | Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof | SCLY, CYP2R1, SPR | GRM8 1104/4885GRM6 807/4885GRIN2D 1965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.